Diabetes Technology Trends: A Review of the Latest Innovations
The Journal of Clinical Endocrinology & Metabolism · 25.02.2025 · 110 (Supplement_2) · S165-S174
DOI: 10.1210/clinem/dgaf034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 25.02.2025. Verfasst von Erika L Lundgrin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Metabolic Care Center, University Hospitals, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Deborah and Ronald Ratner Fund, University Hospitals Mary B. Lee Chair in Endocrinology.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Over the last decade, diabetes management tools such as continuous glucose monitors, automated insulin delivery systems, and connected insulin pens have experienced exponential growth. These technologies are more readily being adopted to manage diabetes due to increased availability. This mini-review provides information about recent innovations available in the United States for diabetes management to improve patient outcomes. Evidence Acquisition A systematic search was conducted using Medline, PubMed, ScienceDirect, and Embase databases, as well as the Cochrane Library to identify peer-reviewed articles published between 2014 and 2024, in English, and focused on treatment using technology in diabetes care. Evidence Synthesis Diabetes technology has significantly eased the burden of both glucose measurement and insulin delivery, which has, overall, improved diabetes management. Advancements in accuracy and glycemic outcomes have been demonstrated through rigorous clinical and observational trials, underscoring their potential to transform diabetes care. The literature suggests that the use of diabetes technologies promotes patient self-efficacy and enhances the quality of life for individuals with both type 2 and type 1 diabetes.
Conclusion
Diabetes technology has been shown to improve important aspects of diabetes care, from glycemic control to patient satisfaction and quality of life. It is important to assess the role of technology in type 1 and type 2 diabetes and individualize treatment goals and objectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes and Metabolic Care Center, University Hospitals, Cleveland, OH 44106, USA.
- Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
- Department of Pediatric Endocrinology, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.
ORCID-Profile: Erika L Lundgrin, Natalie Bellini, Claudia Lewis, Ebne Rafi, Betul Hatipoglu
Förderung
- Deborah and Ronald Ratner Fund
- University Hospitals Mary B. Lee Chair in Endocrinology
Zitieren
APA
Lundgrin, E. L., Kelly, C. A., Bellini, N., Lewis, C., Rafi, E., & Hatipoglu, B. (2025). Diabetes Technology Trends: A Review of the Latest Innovations. The Journal of Clinical Endocrinology & Metabolism, 110(Supplement_2), S165-S174. https://doi.org/10.1210/clinem/dgaf034
Vancouver
Lundgrin EL, Kelly CA, Bellini N, Lewis C, Rafi E, Hatipoglu B. Diabetes Technology Trends: A Review of the Latest Innovations. The Journal of Clinical Endocrinology & Metabolism. 2025;110(Supplement_2):S165-S174. doi:10.1210/clinem/dgaf034
BibTeX
@article{Lundgrin2025,
author = {Lundgrin, Erika L and Kelly, Clare A and Bellini, Natalie and Lewis, Claudia and Rafi, Ebne and Hatipoglu, Betul},
title = {Diabetes Technology Trends: A Review of the Latest Innovations},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {Supplement_2},
pages = {S165--S174},
doi = {10.1210/clinem/dgaf034}
}
EUVIMED